Importing and exporting human tissues and cells between Great Britain (GB) and the European Economic Area (EEA)

The purpose of this survey is to help the HTA identify which activities are impacted by regulatory changes following EU Exit. 

If your establishment imports or exports human tissues and cells between GB and the EEA you may require a HTA licence to continue this activity from 1 July 2021. 

The survey should take no longer than three minutes to complete.

Question Title

* 1. Please provide us with your contact details

Name

Organisation

Role

Email address

Question Title

* 2. What type of organisation are you?

Dental practice

Independent/private hospital

NHS Trust

Other (please specify)

Question Title

* 3. Do you work with human tissue or cells for human application (patient treatment)?

Yes

Question Title

* 4. Do you work with any of the following tissue or cell products?

Amniotic membrane

Acellular bone

Bone

Bone marrow

Cancellous bone particles

Cord blood

Corneas

Demineralised Bone Matrix (DBM)

DBM Putty

Heart valves

Pericardium

Peripheral blood stem cells

Skin and acellular dermis

Starting material for an Advanced Therapy Medicinal Product (ATMP)

Vessels

Other (please specify)

Question Title

* 5. If applicable, where do you send your human tissue products to? (If more than one country, please specify)

Great Britain

an EEA country(ies)

Other (please specify)

None of the above

Question Title

* 6. If you selected an EEA country in question 5, please let us know which country(ies)

Question Title

* 7. If applicable, where do you receive your human tissue products from? (If more than one country, please specify)

Great Britain

an EEA country(ies)

Other (please specify)

None of the above

Question Title

* 8. If you selected an EEA country in question 7, please let us know which country(ies)

Question Title

* 9. Were you already aware of the changes to regulatory requirements following EU exit? If yes, please let us know how:

Yes (please specify)